Suchergebnisse - "Langron, Emily"

PubPharm (7)

1

Fluorescence assay for simultaneous quantification of CFTR ion-channel function and plasma membrane proximity

enthalten in: The Journal of biological chemistry | 2020

von Prins, S. | Langron, E. | Hastings, C. | +4

2

Multitarget CFTR Modulators Endowed with Multiple Beneficial Side Effects for Cystic Fibrosis Patients : Toward a Simplified Therapeutic Approach †

enthalten in: Journal of medicinal chemistry | 2019

von Tassini, S. | Langron, E. | Delang, L. | +18

3

Potentiation of the cystic fibrosis transmembrane conductance regulator by VX-770 involves stabilization of the pre-hydrolytic, O1 state

enthalten in: British journal of pharmacology | 2018

von Langron, E. | Prins, S. | Vergani, P.

4

Improved fluorescence assays to measure the defects associated with F508del-CFTR allow identification of new active compounds

enthalten in: British journal of pharmacology | 2017

von Langron, E. | Simone, M. | Delalande, C. | +3

5

Discovery of Multitarget Agents Active as Broad-Spectrum Antivirals and Correctors of Cystic Fibrosis Transmembrane Conductance Regulator for Associated Pulmonary Diseases

enthalten in: Journal of medicinal chemistry | 2017

von Tassini, S. | Sun, L. | Lanko, K. | +15

6

Gain and loss of function of P2X7 receptors : mechanisms, pharmacology and relevance to diabetic neuropathic pain

enthalten in: Molecular pain | 2014

von Ursu, D. | Ebert, P. | Langron, E. | +10

7

Pharmacological characterisation of ligand- and voltage-gated ion channels expressed in human iPSC-derived forebrain neurons

enthalten in: Psychopharmacology | 2014

von Dage, J. | Colvin, E. | Fouillet, A. | +12

1
[1]